Animal Health Market Size, Share and Manufacture Development Analysis by 2025-2030

Global Animal Health Market Overview

The global animal health market is anticipated to grow at a CAGR of approximately 8–9% through 2029, driven by rising awareness of veterinary healthcare, increased demand for protein-rich foods such as meat, milk, fish, and eggs, and the growing prevalence of zoonotic and food-borne diseases. Additionally, surging companion animal adoption, coupled with expanding R&D investments in veterinary medicines and vaccines, continues to propel market growth.

Download Sample Copy: https://meditechinsights.com/animal-health-market/request-sample/

Understanding Animal Health

Animal health encompasses the prevention, diagnosis, and treatment of diseases, disorders, and injuries affecting both domesticated and wild species. It involves a broad array of solutions, including vaccines, anti-infective and antiparasitic drugs, fertility management products, and nutritional supplements, as well as innovative delivery systems and performance technologies. Beyond traditional care, modern animal health now integrates digital tools, livestock data management platforms, and pet recovery services, marking a shift toward more connected, efficient, and preventive veterinary practices.

Technological Innovations Transforming the Animal Health Market

The animal health industry is undergoing a technological revolution, with advancements in AI, diagnostics, smart sensors, and precision medicine improving disease prediction, prevention, and treatment. The growing emphasis on preventive care and personalized veterinary medicine is fostering demand for advanced therapeutics, diagnostic platforms, and digital solutions.

Notable Developments Include:

• January 2024: Merck Animal Health received European Commission approval for BRAVECTO® (fluralaner) 150 mg/ml, a long-lasting injectable solution for flea and tick protection in dogs.
• April 2022: Zoetis enhanced its diagnostic capabilities with AI-powered blood smear testing integrated into its Vetscan Imagyst™ platform—expanding in-clinic diagnostic capabilities for veterinarians.
• January 2022: Zoetis introduced new digital solutions to its Performance Ranch™ and BLOCKYARD™ platforms to improve cattle data management.
• June 2021: Vetoquinol launched Phovia, a device designed to accelerate skin healing in dogs and cats.

Together, these innovations underscore the shift toward faster, safer, and data-driven veterinary care, improving both animal welfare and healthcare efficiency.

Rising Pet Ownership Driving Market Demand

Pet ownership has grown dramatically across the globe, with over 50% of households in major markets now owning a pet—and adoption rates reaching over 80% in countries like Brazil and Argentina. Pets are increasingly recognized not just as companions, but as contributors to human emotional and physical well-being.

Research indicates that pet owners experience lower stress levels, better community engagement, and stronger social connections compared to non-pet owners. This growing human-animal bond is fueling demand for veterinary products such as parasiticides, antimicrobials, vaccines, feed additives, and growth promoters, supporting steady market expansion in the years ahead.

Regional Insights: North America Leads, APAC Rising

North America currently dominates the global animal health market, driven by:

• A high rate of pet ownership (over 67% of U.S. households)
• Growing cases of zoonotic diseases
• Increased spending on pet healthcare
• Government-led animal welfare initiatives
• Strong technological and R&D ecosystems

Europe remains a key region, particularly in Germany, the U.K., and France, where rising awareness and rapid adoption of modern veterinary technologies support market expansion.

Meanwhile, the Asia-Pacific region (APAC) is expected to experience the fastest growth, fueled by rising disposable incomes, greater pet adoption, and heightened investments in veterinary R&D to produce innovative medicines and vaccines.

Market Segmentation

By Product Type

The market is divided into pharmaceuticals, vaccines, feed additives, and diagnostics:

• Pharmaceuticals and vaccines dominate the market, accounting for the largest share due to their critical role in disease prevention and control.
• Medicinal feed additives—including probiotics, prebiotics, and amino acids—support animal nutrition and performance but represent a smaller market segment.
• Diagnostics, such as rapid testing kits and laboratory assays, are experiencing significant growth driven by early detection trends and advances in veterinary technology.

By Animal Type

• Livestock animals (cattle, poultry, and swine) form the largest segment, driven by global protein demand and large-scale production.
• Companion animals (dogs, cats, and horses) represent a rapidly growing market due to the rising trend of pet humanization and the increasing use of specialized veterinary care.

Understanding the distinct healthcare needs of these two segments is critical for market players aiming to align their strategies with evolving industry demands.

Competitive Landscape

The animal health industry is highly competitive, with established companies and emerging innovators shaping the landscape. Key players include:
Merck Animal Health, Ceva Sante Animale, Vetoquinol S.A., Zoetis, Boehringer Ingelheim GmbH, Elanco, IDEXX Laboratories, Heska Corporation, Covetrus, Virbac, Mars Inc., Phibro Animal Health Corporation, Dechra Pharmaceuticals, Neogen, B. Braun Vet Care, Nutreco N.V., Genus PLC, and SeQuent Scientific Ltd., among others.

Strategic Developments

Market players are pursuing both organic and inorganic growth strategies—including mergers, acquisitions, partnerships, and product launches—to strengthen their presence.

• February 2024: Merck Animal Health announced plans to acquire Elanco Animal Health’s aquatic-focused division for $1.3 billion, expanding its portfolio in fish and aquatic species health.
• June 2022: Zoetis acquired Basepaws, a pet genetics company, enhancing its presence in precision animal health and personalized pet diagnostics.
• June 2022: Boehringer Ingelheim partnered with CarthroniX to develop novel small-molecule therapies for canine oncology.
• April 2022: Elanco formed a strategic alliance with Royal DSM to commercialize Bovaer®, a first-in-class feed additive that reduces methane emissions in cattle.
• January 2022: Zoetis received FDA approval for Solensia™, a monoclonal antibody treatment for osteoarthritis pain in cats, marking a breakthrough in veterinary biologics.

These strategic initiatives highlight the industry’s ongoing commitment to innovation, sustainability, and precision medicine.

Get Report Details @ https://meditechinsights.com/animal-health-market/

Conclusion

The global animal health market is poised for sustained growth, supported by technological advancements, rising pet ownership, and increasing awareness of veterinary wellness. As the industry evolves, innovations in AI, diagnostics, biologics, and preventive care are redefining the standards of animal treatment.

With continued R&D investments, new product launches, and strategic partnerships, leading players are positioning themselves to meet growing global demand and shape the next generation of animal healthcare.

About Medi-Tech Insights ;

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com